Uploaded July 2023 | Updated September 2026, 1 week ago

---

Insilico Medicine founder & CEO Alex Zhavoronkov shares the latest updates -- including 12 preclinical candidates and three clinical stage assets delivered from Insilico's end-to-end generative AI platform -- from inside Insilico's fully automated AI-powered robotics lab.

"I think that AI can definitely transform the pharmaceutical industry in a big way."

#pharma #ai #generativeai #drugdiscovery